|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM161073034 |
003 |
DE-627 |
005 |
20250207044025.0 |
007 |
tu |
008 |
231223s2006 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a pubmed25n0537.xml
|
035 |
|
|
|a (DE-627)NLM161073034
|
035 |
|
|
|a (NLM)16515886
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Manske, Michelle K
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Quantitative analysis of clonal bone marrow CD19+ B cells
|b use of B cell lineage trees to delineate their role in the pathogenesis of light chain amyloidosis
|
264 |
|
1 |
|c 2006
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 03.08.2006
|
500 |
|
|
|a Date Revised 22.03.2007
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a ErratumIn: Clin Immunol. 2007 Mar;122(3):356
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Light chain amyloidosis (AL) is a bone marrow (BM) plasma cell neoplasia with systemic deposition of Ig light chain amyloid fibrils. Here, we report the identification of clonal CD19 B cells in the BM and the use of a novel mathematical algorithm to generate B cell lineage trees of the clonal CD19 B cells and CD138 plasma cells from the BM of AL patients to delineate the relationship between these two clonal populations. The CD19+ clonal B cells in the BM of AL patients related to the clonal plasma cells represent a pre-plasma cell precursor population. The B cell lineage trees from AL patients also show significant differences in clonal diversification and antigenic selection compared to clones from normal, healthy controls. These data provide a robust example of the use of graphical quantification methods in delineating the role of neoplastic precursors in the pathogenesis of hematopoietic malignancies
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a Antigens, CD19
|2 NLM
|
650 |
|
7 |
|a Immunoglobulin Light Chains
|2 NLM
|
650 |
|
7 |
|a Membrane Glycoproteins
|2 NLM
|
650 |
|
7 |
|a Proteoglycans
|2 NLM
|
650 |
|
7 |
|a SDC1 protein, human
|2 NLM
|
650 |
|
7 |
|a Syndecan-1
|2 NLM
|
650 |
|
7 |
|a Syndecans
|2 NLM
|
650 |
|
7 |
|a RNA
|2 NLM
|
650 |
|
7 |
|a 63231-63-0
|2 NLM
|
700 |
1 |
|
|a Zuckerman, Neta S
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Timm, Michael M
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Maiden, Stephanie
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Edelman, Hanna
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Shahaf, Gitit
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Barak, Michal
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Dispenzieri, Angela
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Gertz, Morie A
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Mehr, Ramit
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Abraham, Roshini S
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 120(2006), 1 vom: 15. Juli, Seite 106-20
|w (DE-627)NLM098196855
|x 1521-6616
|7 nnns
|
773 |
1 |
8 |
|g volume:120
|g year:2006
|g number:1
|g day:15
|g month:07
|g pages:106-20
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 120
|j 2006
|e 1
|b 15
|c 07
|h 106-20
|